King Abdulaziz Medical City
Jeddah, WR, 21423, Saudi Arabia
NCT Number: NCT03726697
Tahneek is an Arabic word which means putting something sweet such as dates, in the infant's mouth after the birth. Neonatal hypoglycemia is common in the first few days after birth. Up to 15 % of normal newborn babies will have low blood glucose concentrations. It has been demonstrated that treatment of neonatal hypoglycemia with oral dextrose gel was more effective than feeding alone in reversing the hypoglycemia, and also reduced the rate of NICU admission. investigators study is using dates to asses its effect on hypoglycemia in infants at risk.
Looking for future studies?
Notify MeUp to 1 hour
All sexes
Interventional
Not applicable
Jeddah, WR, 21423, Saudi Arabia
Tahneek is an Arabic word which means putting something sweet such as dates, in the infant's mouth after the birth. It is a noble practice in Islam, with which the newborn is greeted upon entering into life, usually before milk feeds. It is done by rubbing a softened date on the palate of the new-born just after the birth. The tahneek also exercises the muscles of the mouth and helps with the circulation of blood in the mouth - this may help the baby to be able to suck and take mother's milk. Neonatal hypoglycemia is common in the first few days after birth. Up to 15 % but the incidence in babies with risk factors is much greater upto 50 % in infants of diabetic mothers, large and small babies and 66 % in preterm babies. Neonatal hypoglycemia is associated with brain damage, death and developmental delay in later life. Treatment of neonatal hypoglycemia with oral dextrose gel was more effective than feeding alone in reversing hypoglycemia, and thus reducing the rate of NICU admission for hypoglycemia. investigators study is using dates to asses its effect on hypoglycemia in infant at risk.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A single dose of soft date containing glucose equivalent to 200mg/kg at 1 h after birth will be massaged into the buccal mucosa of the palate and cheek from right to left side, until the date paste is fully absorbed
Time frame: first 48 hours of life
infants who meet eligibility criteria and parents have consented will receive a single dose of soft date, prepacked by the pharmacy containing glucose equivalent to 200mg/kg within 1 h after birth. Assess glucose level after 1 feed compared to controls with similar risk factors who are not received Tahneek. hypoglycemia defined as any blood glucose concentration < 2.6 mmol/L.
Time frame: first 48 hours of life
infants at-risk will be followed to measure NICU admission data and glucose values during hospitalization.
Time frame: 48 hours
infants at-risk who received Tahneek will be followed until hospital discharge to measure NICU admission data and glucose values during hospitalization. hyperglycemia defined as any blood glucose concentration > 10 mmol/L.
Time frame: 6 months
will asses the breastfeeding rate in the study infants, compared to controls at discharge from hospital (full or exclusive) and at 6months of age.
Time frame: 48 hours
Pain scale as measured by Neonatal intensive pain scale during the first 48 hrs of hospital stay
King Abdullah International Medical Research Center
Other
Effect of Tahneek With Dates on Hypoglycemia in Newborn Infants: A Randomised Control Trial
Acronym: THIN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02523222
Birth Weight, Body Weight
Houston, Texas, United States
View Trial DetailsNCT06653374
Abruptio Placentae, Asphyxia Neonatorum
Quito, Pichincha, Ecuador
View Trial DetailsNCT02605369
Death, Female Urogenital Diseases and Pregnancy Complications
Lira, Uganda
View Trial DetailsNCT06794307
Female Urogenital Diseases and Pregnancy Complications, Glucose Metabolism Disorders
Aarhus, Central Region Denmark, Denmark
View Trial Details